MedPath

Etiology and Early Diagnosis of Neurodevelopmental Disorders

Completed
Conditions
Neurodevelopmental Disorders
Registration Number
NCT02003170
Lead Sponsor
University of Arkansas
Brief Summary

The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.

Detailed Description

Although neurodevelopmental disorders are very prevalent (for example Autism affects 1 out of every 88 children and dyslexia affects up to 15% of the population), the etiology of such disorders is not known. The purpose of this investigation is to identify common etiologies of neurodevelopmental disorders (i.e., speech delay, global developmental delay, autism) and determine if it is possible to find early indicators of the diagnosis and foster the potential for a better prognosis of these disorders. At this time the investigators examine patients with neurodevelopment disorders with various medical investigations, but the results of these investigations are not systematically evaluated. One of the goals of this research is to systematically examine this information in order to identify patterns of test abnormalities that have not been previously described. Another goal of this research is to identify the common etiologies typically identified by the medical evaluation, so we can further refine our approach. In addition, the investigators now have the ability to evaluate biological samples for biomarkers that have potential to be diagnostically useful.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
576
Inclusion Criteria
  • Neurodevelopmental delays
  • Clinical visit at an Arkansas Children's Hospital Outpatient clinic
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Medical abnormalities associated with specific neurodevelopmental disordersup to 7 years

It is unknown if a specific set of biological abnormalities contribute to the formation of many types of neurodevelopmental disorders. The study is intended to identify the relationship between biological abnormalities and neurodevelopmental disorders

Secondary Outcome Measures
NameTimeMethod
Treatments associated with neurodevelopmental disordersup to 7 years

Various behavioral and medical treatments are used for many types of neurodevelopmental disorders but the effectiveness for many of these treatments is not known. The study is intended to identify the relationship between biological abnormalities (and their treatments) and neurodevelopmental disorders

Biomarkers associated with neurodevelopmental disordersup to 7 years

It is unknown if a specific biomarkers are associated with specific neurodevelopmental disorders. The study is intended to identify the relationship between biological abnormalities and neurodevelopmental disorders

Trial Locations

Locations (1)

Arkansas Children's Hospital Research Institute

🇺🇸

Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath